News & Media
Case Updates

On January 18, 2023, Wolf Popper filed a class action against Y-mAbs Therapeutics, Inc. and certain of its senior executives on behalf of all persons or entities who purchased shares of Y-mAbs common stock (NASDAQ: YMAB) on the open market, or pursuant to Registration Statements filed with the Securities and Exchange Commission, during the period October 6, 2020 through October 28, 2022 (the “Class Period”).
 
Class members have until Monday, March 20, 2023, to seek appointment as lead plaintiff in the class action.
 

• Phone: Robert C. Finkel – (212) 451-9620
• Phone: Joshua W. Ruthizer – (212) 451-9668
• Phone: Adam Savett – (212) 451-9655
• Email: Outreach@wolfpopper.com
• Contact Us About This Case